Institution statistics

HELLENIC PASTEUR INSTITUTE - Greece 

Ranking results:

Past rankings:
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:400-500
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:500-600
Project Leadership Index:600-700
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:600-700
Project Leadership Index:600-700
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Partner Constancy:500-600
Project Leadership Index:500-600
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 21
As coordinator: 2
As participant: 18
Sole participant: 1
Coordinator / Participant Ratio: 0.11*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2016 0 1.443.927 47.187 1
2014 0 3.894.894 230.319 1
2011 0 434.700 48.300 1
2010 1.869.910 3.600.000 1.930.936 1 1
2009 0 5.917.421 493.118 1
2008 0 11.025.000 459.375 1
2006 0 5.194.460 581.808 2
2005 0 19.669.439 891.234 2
2004 0 600.000 27.273 1
2002 1.822.984 1.310.600 415.102 1 1
2001 1.629.992 3.332.727 586.334 1 2
2000 0 7.523.406 1.012.002 4
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE8
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE7
INSTITUT PASTEUR4
KAROLINSKA INSTITUTE4
INSERM TRANSFERT3
INSTITUTO DE SALUD CARLOS III3
PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
UNIVERSITE DE GENEVE3
UNIVERSITY COLLEGE LONDON3
WEIZMANN INSTITUTE OF SCIENCE3
BERNHARD NOCHT INSTITUT FUER TROPENMEDIZIN2
CONSIGLIO NAZIONALE DELLE RICERCHE2
DEPARTMENT OF HEALTH2
FOLKHALSOMYNDIGHETEN2
FRIEDRICH LOEFFLER INSTITUT BUNDESFORSCHUNGSINSTITUT FUER TIERGESUNDHEIT2
INSTITUTO NACIONAL DE SAUDE DR RICARDO JORGE2
ISTITUTO SUPERIORE DI SANITA2
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
MAXPLANCKGESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
MEDIZINISCHE UNIVERSITAT GRAZ2
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS2
ORSZAGOS EPIDEMIOLOGIAI KOZPONT2
PHILIPPS UNIVERSITAET MARBURG2
PROTEOSYS2
REGULON AE2
RHEINISCHE FRIEDRICH WILHELMS UNIVERSITAET BONN2
ROBERT KOCH INSTITUT2
SPITALUL CLINIC DR VICTOR BABES BUCURESTI SVB2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE2
UNIVERSITA DEGLI STUDI DI FERRARA2
UNIVERSITAET KONSTANZ2
UNIVERSITE CLAUDE BERNARD LYON 12
UNIVERSITE DE PARISSUD XI2
UNIVERSITY OF MAASTRICHT2
AGRICULTURAL UNIVERSITY OF ATHENS1
AGRICULTURAL UNIVERSITY OF NORWAY1
ALQUDS UNIVERSITY1
ASLA BIOTECH1
AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY1
AZIENDA OSPEDALIERA NIGUARDA CA'GRANDA1
BEACTICA AB1
BELDEM1
BIOKINE THERAPEUTICS1
BIOVITRUM AB1
CAPIO DIAGNOSTIK CALAB RESEARCH AB1
CELONIC1
CENTRE NATIONAL DE LE RECHERCHE SCIENTIFIQUE1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
CYCLOLAB CIKLODEXTRIN KUTATO FEJLES1
CYTOS BIOTECHNOLOGY1
DEXTER COM1
DIAMED EUROGEN NV1
DIREVO BIOTECH1
EGE UNIVERSITY MEDICAL SCHOOL DEPARTMENT OF PARASITOLOGY1
EISAI LONDON RESEARCH LABORATORIES1
ELI LILLY COMPANY LIMITED1
EPIXIS1
EPSILONBIOTECH BVBA1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ERASMUS UNIVERSITEIT ROTTERDAM1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA1
FONDAZIONE SANTA LUCIA1
FREIE UNIVERSITAET BERLIN1
FRIEDRICHALEXANDER UNIVERSITAET ERLANGENNUERNBERG1
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA1
FUNDATIA DR VICTOR BABES1
GENMAB1
GENOPOIETIC1
GENOPOLIS CONSORZIO DI GENOMICA FUNZIONALE1
GERMAN CANCER RESEARCH CENTER1
GOETEBORGS UNIVERSITET1
HACETTEPE UNIVERSITESI1
HADASSAH MEDICAL ORGANIZATION1
HASKOLI ISLANDS1
HEALTH PROTECTION AGENCY1
HIQSCREEN SARL1
HOSPITAL DE EGAS MONIZ1
HUMBOLDTUNIVERSITAET BERLIN1
HYCULT BIOTECHNOLOGY BV1
IMMUNID1
INSTITUT AGRONOMIQUE ET VETERINAIRE HASSAN II1
INSTITUT PASTEUR D'ALGERIE'1
INSTITUT PASTEUR DE TUNIS1
INSTITUTE OF BIOTECHNOLOGY1
INSTITUTE OF HEALTH CARLOS III1
INSTITUTE OF PARASITOLOGY ACADEMY OF SCIENCES OF THE CZECH REPUBLIC1
INSTITUTE OF TROPICAL MEDICINE PRINCE LEOPOLD1
INSTITUTO DE HIGIENE E MEDICINA TROPICAL NA UNIVERSIDADE NOVA DE LISBOA1
ISTITUTO NAZIONALE MALATTIE INFETTIVE LSPALLANZANI IRCCS1
ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANIISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO1
ISTITUTO ZOOPROFILATICO SPERIMENTALE DELLA PUGLIA E DELLA BASILICATA1
JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KING'S COLLEGE LONDON1
KLINIKUM DER UNIVERSITAET REGENSBURG1
LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE1
Constancy:

Total number of partners:228

Partner loyalty:
Frequent Partner: (> 2 projects): 44
Rare Partner: 184

Frequent / Rare Partner Ratio: 0.24

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES18
RTD HORIZONTAL TOPICS12
SOCIAL AND ECONOMIC CONCERNS6
PROTECTING MAN AND HIS ENVIRON4
AGRICULTURE AND MARINE RESOURC1
INDUSTRY AND TECHNOLOGY1

Project overview:

Start dateProjectacronymrolefundingpartners
2016-01-01European Research Infrastructure on Highly Pathogenic Agents 2 ERINHA2participant1.443.92716
2014-03-01NANOCARRIERS FOR THE DELIVERY OF ANTIMICROBIAL AGENTS TO FIGHT RESISTANCE MECHANISMS CYCLON HITparticipant3.894.89411
2011-04-01Exploring Chemical Biodiversity with Innovative Approaches for Fighting Chagas and Leismaniasis ChemBioFightparticipant434.7005
2010-11-01European Research Infrastructure on Highly Pathogenic Agents ERINHAparticipant3.600.00025
2010-09-01Development of a Center of Excellence in Neurosignalling NeuroSigncoordinator1.869.9101
2009-12-01Myasthenias, a group of immune mediated neurological diseases: from etiology to therapy FIGHT-MGparticipant5.917.42112
2008-02-01Neurotransmitter Cys-loop receptors: structure, function and disease NEUROCYPRESparticipant11.025.00024
2006-10-01Development of models to improve management of Myasthenia Gravis: From basic knowledge to clinical application MYASTAIDparticipant2.700.00010
2006-01-01Targeted Herpesvirus-derived Oncolytic Vectors for Liver cancer European Network THOVLENparticipant2.494.4608
2005-11-01Neuroprotective strategies for multiple sclerosis NEUROPROMISEparticipant11.399.99725
2005-01-01Ration design and standardized evaluation of novel genetic vaccines. COMPUVACparticipant8.269.44219
2004-12-01Monitoring risk factors of spreading of leishmaniasis around the Mediterranean basin LEISH-MEDparticipant600.00022
2002-01-01Innovative therapeutics for the prototype autoimmune disease, myasthenia gravis IMMUNOTHERAPEUTICScoordinator1.822.9848
2002-01-01Molecular analysis and mechanistic elucidation of the functionality of probiotics and prebiotics in the inhibition of pathogenic microorganisms to combat gastrointestinal disorders and to improve human health PROPATHparticipant1.310.6007
2001-12-01Structural basis of nicotinic acetylcholine receptor function (NICOTINIC RECEPTORS) NICOTINIC RECEPTORScoordinator1.629.9927
2001-11-01Understanding the mechanism of autoimmunity through myasthenia gravis (MECHANISMS OF MG) MECHANISMS OF MGparticipant1.818.5179
2001-09-01Diagnostic and epidemiological markers for tracking of endemic and resurgent european leishmaniasis LEISHMANIA GENOTYPINparticipant1.514.21010
2000-12-01Engineering neural precursors for myelin repair STEM CELLS FOR REPAIparticipant1.409.9067
2000-12-01Genes controlling neuronal specification and differentiation NEUROGENESIS CONTROLparticipant1.597.9246
2000-09-01Central facility for the production of stabilised cellular reference standards and external quality assessment in clinical flow cytometry EUROSTANDARDSparticipant2.749.95511
2000-02-01European (euro) network for development of novel safe vaccines based on new generation amplicons (amp) and other defective hsv-1 derived vectors as foreign antigen delivery systems. EUROAMPparticipant1.765.6216

Alias institution names:
  • HELLENIC PASTEUR INSTITUTE

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum